✓ Η πληρωμή με πιστωτική κάρτα αποκαταστάθηκε — ασφαλής ολοκλήρωση αγοράς μέσω Privacy Shield

Aprecap

Aprecap (Aprepitant 125/80 mg) — Cipla NK1 receptor antagonist antiemetic for prevention of acute and delayed chemotherapy-induced nausea/vomiting.

Ιατρικά ελεγμένο από Morgan Ellis — Ερευνητής Φαρμακευτικής · 8 χρόνια εμπειρία  · Τελευταία αναθεώρηση: Μάιος 2026

Κρυπτογραφημένη αγορά
Η πληρωμή με κρυπτονομίσματα κοστίζει 10% λιγότερο
Διακριτική παγκόσμια αποστολή
1,400+ πελάτες · 50+ χώρες

Αυτό το προϊόν είναι προσωρινά εξαντλημένο και μη διαθέσιμο.

Γρήγορη απάντηση

Aprecap — Aprepitant 125 mg/80 mg (Cipla Inc). NK1 receptor antagonist antiemetic for prevention of acute and delayed nausea/vomiting from highly and moderately emetogenic chemotherapy (cisplatin, AC, MEC). Used in combination with 5-HT3 antagonist + dexamethasone.

Αυτό που λαμβάνετε με την MedsBase:

  • πιστοποιημένο από τη WHO-GMP κατασκευαστή
  • Discreet plain-envelope packaging
  • Παγκόσμια αποστολή
  • Rated by 1,400+ customers (read reviews)

📦 Reshipment Assurance: if your order has not arrived 20 business days after dispatch, we reship it at no extra cost. Read the policy.

Γιατί να παραγγείλετε από τη MedsBase

Aprecap ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.

⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.

CYP3A4 interactions
Aprepitant is a moderate CYP3A4 inhibitor. Significant interactions with dexamethasone (raises levels — dose-reduce dexamethasone 50%), warfarin (transient INR fall), oral contraceptives (efficacy reduced — use additional non-hormonal method during therapy and for 1 month after).

Συχνές Ερωτήσεις

When is this used?

NK1 receptor antagonist antiemetic for prevention of acute and delayed nausea/vomiting from highly and moderately emetogenic chemotherapy (cisplatin, AC, MEC). Used in combination with 5-HT3 antagonist + dexamethasone.

Side effects?

Class-specific — see safety boxes above. Most supportive cancer medications are well-tolerated when used per protocol but require specialist supervision.

Drug interactions?

Always disclose all medications. Cancer supportive therapy interacts with multiple cytotoxics, chemo regimens, and concomitant medications.

Pregnancy?

Variable by molecule. Consult oncology for pregnancy planning during cancer therapy.

Monitoring?

Specialist-determined — typically FBC, electrolytes, renal/liver function, cardiac monitoring as relevant.

Τι γίνεται αν χάσω μια δόση;

Take when you remember; do not double up. Discuss with oncology team if multiple doses missed.

When is treatment finished?

Determined by clinical response, planned regimen length, and patient tolerance.

Storage?

Per package insert — typically below 25-30°C, away from light and moisture. Pregnant household members should not handle broken tablets/capsules.

Cost?

Generic Indian biosimilars and chemical equivalents are dramatically less expensive than originator products with documented bioequivalence and clinical equivalence.

Vaccines?

Coordinate with oncology — live vaccines may be contraindicated during cancer therapy.

Other Cancer & Supportive Medications

  • Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
  • Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
  • Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
  • Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
  • Actorise — darbepoetin alfa — for chemotherapy-induced anaemia
Ιατρική Αποποίηση Ευθυνών: Cancer therapy is highly individualised. Specific drug, dose, schedule, monitoring, and supportive care must be determined by a qualified oncologist or haematologist based on tumour biology, staging, comorbidities, and goals of care. This information is educational; it does not substitute for professional medical advice.

More options in Anti Cancer Medication

Ταξινομημένα σύμφωνα με τον όγκο παραγγελιών στο MedsBase — τι επιλέγουν άλλοι πελάτες σε αυτήν την κατηγορία.

Ισχύς

125 mg

Ποσότητα

3 Capsule/s, 6 Capsule/s, 9 Capsule/s

Φαρμακευτική Μορφή

Δισκία

Κατασκευαστής

Glenmark Pharmaceuticals

Θεραπεία

Nausea and vomiting due to chemotherapy

Γενόσημη μάρκα

Aprepitant

Κριτικές

Δεν υπάρχουν ακόμη κριτικές

Προσθήκη κριτικής
Aprecap Aprecap
Αξιολόγηση*
0/5
* Η αξιολόγηση είναι υποχρεωτική
* Η απάντηση είναι υποχρεωτική
Η κριτική σας
* Η κριτική είναι υποχρεωτική
Όνομα
* Απαιτείται όνομα
Προσθέστε φωτογραφίες ή βίντεο στην κριτική σας

Ερωτήσεις & Απαντήσεις

Κάντε μια ερώτηση
Aprecap Aprecap
Η ερώτησή σας
* Απαιτείται ερώτηση
Όνομα
* Απαιτείται όνομα
Δεν υπάρχουν ακόμα ερωτήσεις